About us > Research
The workgroup psychoses is active in numerous research fields that can be roughly divided into care research, pharmacotherapy, imaging and neuropsychology. The following table presents a selection of current research projects of the Workgroup Psychoses :
 |
 |
| Care research | |
| Medication non-adherence and service disengagement in patients with schizophrenia spectrum disorders treated with Quetiapine fumarate comparing Assertive Community Case Management (ACCM) with Treatment-as-usual (TAU). | PD Dr. M. Lambert PD Dr. T. Bock |
| Durchführung und Evaluation des Projektes HopeS (Hilfe und Orientierung für psychisch erkrankte Studierende | PD Dr. T. Bock, T. Flögel, M. Doose |
| Entwicklung und Evaluation eines Curriculums für "Experienced Involvement" | PD Dr. T. Bock, G. Sielaff, A. Rieth |
| First episode research | |
| A prospective, single-centre, 8 weeks acute phase-IV study investigating efficacy, tolerability and safety of Quetiapine fumarate in 60 drug-naïve first-episode psychosis patients aged 15 to 30 years. | PD Dr. M. Lambert Dr. C. Huber Dr. B. G. Schimmelmann |
| A prospective 2 years follow-up study in first-episode psychosis. | PD Dr. M. Lambert |
| Investigation of the Efficacy of Olanzapine and Lithium versus Chlorpromazine and Lithium in patients with first manic episode | PD Dr. P. Conus PD Dr. M. Lambert |
| 10-year follow-up of an epidemiological cohort of 661 first-episode psychosis patients who were admitted to the Early Psychosis Prevention and Intervention Centre (EPPIC) between 1998-2000 and treated for up to 18 months. |
PD Dr. M. Lambert PD Dr. P. Conus Dr. B. G. Schimmelmann |
| Imaging | |
| Attention, Executive Function and Biological Response to Quetiapine in Patients with Schizophrenia - an fMRI-study | Dr. C. Huber |
| Intervention research | |
| Vergleich einer speziellen Gruppentherapie gegen TAU (inklusive Psychoedukation) | PD Dr. T. Bock, Dr. A. Koessler, Dr. D. Schöttle, Stefan |
| Metakognitives Training für schizophrene Patienten (einfach-blinde Vergleichstudie mit aktiver Kontrollbedingung, CogPack, und follow-up) | PD Dr. Steffen Moritz, Ruth Klinge, Dr. Lena Jelinek |
| Source memory and memory confidence in schizophrenia | PD Dr. Steffen Moritz |
| Die Effektivität Kognitiv-Motivationaler Therapie vs. supportiver Suchttherapie bei jugendlichen und jungerwachsenen Patienten mit Psychose und komorbider Suchtstörung: eine cluster-randomisierte Studie | PD Dr. M. Lambert, Dr. M. Burlon PD Dr. T. Bock |
| Medication studies (examples) | |
| A Randomized, Double Blind, Parallel-Group Comparative Study of Flexibly Dosed Paliperidone Palmitate (25, 50, 75, or 100 mg eq.) Administered Every 4 Weeks and Flexibly Dosed RISPERDAL CONSTA (25, 37.5, or 50 mg) Administered Every 2 Weeks in Subjects with Schizophrenia. Protocol R092670-PSY-3002; Phase 3 |
PD Dr. M. Lambert Dr. C. Huber |
| A sixteen-week, multi-center, open-label study evaluating the safety, tolerability, and efficacy of switching from quetiapine to Ziprasidone in subjects diagnosed with Schizophrenia or Schizoaffective Disorder Protocol A1281148; Phase 4 |
PD Dr. M. Lambert Dr. C. Huber |
| An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects with Schizophrenia. Protocol R076477SCH3017; Phase 3b | PD Dr. Lambert |
| Subject orientated research | |
| Entwicklung und Einsatz des Hamburger SuSi-Fragebogens zum subjektiven Sinn von Psychosen | PD Dr. T. Bock, Tanno Bryzinski, Prof. Naber, u.a. |
| Durchführung und Evaluation der Antstigmaarbeit von "Irre menschlich Hamburg" | PD Dr. T. Bock , R. Dorner |
 |
Research |
